The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy
- 21 August 2016
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 135 (6) , 656-662
Abstract
To characterize changes in motor nerve conduction studies (MNCS) and motor unit number index (MUNIX) following treatment with subcutaneous immunoglobulin and to assess whether these changes are related to muscle strength. Data from 23 patients participating in a randomized, controlled trial were analyzed. MNCS and MUNIX were performed before and after 12 weeks of treatment. Isokinetic strength (IMS) was measured in various muscles together with grip strength (GS). Proximally evoked compound muscle action potential (CMAP) amplitudes and MUNIX tended to be better preserved in treated patients (P=.049 and .045). Changes in other parameters did not differ between groups. There was no correlation between changes in electrophysiological parameters and IMS. Changes in GS were related to median nerve motor conduction velocity, distal motor latency, CMAP amplitudes, and distally evoked CMAP duration (P=.013–.035). Proximally evoked CMAP amplitudes appear to be the best MNCS parameter to assess treatment outcome in chronic inflammatory demyelinating polyneuropathy.Keywords
This publication has 28 references indexed in Scilit:
- Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitusActa Neurologica Scandinavica, 2015
- Chronic Inflammatory Demyelinating PolyneuropathyCurrent Treatment Options in Neurology, 2013
- Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathyClinical Neurophysiology, 2012
- Current status on electrodiagnostic standards and guidelines in neuromuscular disordersClinical Neurophysiology, 2011
- Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathyEuropean Journal of Neurology, 2011
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First RevisionJournal of the Peripheral Nervous System, 2010
- Length‐dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 2008
- Correlations of nerve conduction measures in axonal and demyelinating polyneuropathiesClinical Neurophysiology, 2007
- Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelinesClinical Neurophysiology, 2005
- Motor Unit Number Index (MUNIX)IEEE Transactions on Biomedical Engineering, 2004